Heparan sulfate proteoglycan as a plasma membrane carrier

Trends in Biochemical Sciences

Volumn 28, Issue 3, 2003, Pages 145-151

  Belting, Mattias ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN; CARRIER PROTEIN; FIBROBLAST GROWTH FACTOR; NUCLEIC ACID; PEPTIDE; PROTEOHEPARAN SULFATE; VIRUS PROTEIN;

ANGIOGENESIS; BINDING AFFINITY; BIOSYNTHESIS; CELL GROWTH; CELL MEMBRANE; CELL SURFACE; CELL TRANSPORT; ENDOCYTOSIS; EXTRACELLULAR SPACE; GENE THERAPY; GENE TRANSFER; INTRACELLULAR SPACE; LIPID BILAYER; LIPID METABOLISM; MEMBRANE PERMEABILITY; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; REVIEW; VIRUS; WOUND HEALING;

MAMMALIA;

EID: 0037333830     PISSN: 09680004     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0004(03)00031-8     Document Type: Review

References (48)

1. Crystal R.G. Transfer of genes to humans: early lessons and obstacles to success. Science. 270:1995;404-410.
2. Ferber D. Gene therapy. Safer and virus-free? Science. 294:2001;1638-1642.
3. Davis M.E. Non-viral gene delivery systems. Curr. Opin. Biotechnol. 13:2002;128-131.
4. Derossi D., et al. Trojan peptides: the penetratin system for intracellular delivery. Trends Cell Biol. 8:1998;84-87.
5. Elliott G., O'Hare P. Intercellular trafficking and protein delivery by a herpesvirus structural protein. Cell. 88:1997;223-233.
6. Zhennan L., et al. Intercellular delivery of a herpes simplex virus VP22 fusion protein from cells infected with lentiviral vectors. Proc. Natl. Acad. Sci. U. S. A. 97:2000;11297-11302.
7. Xia H. The HIV Tat protein transduction domain improves the biodistribution of β-glucuronidase expressed from recombinant viral vectors. Nat. Biotechnol. 19:2001;640-644.
8. Lundberg M., Johansson M. Is VP22 nuclear homing an artifact? Nat. Biotechnol. 19:2001;713-714.
9. Leifert J.A., et al. Full-length proteins attached to the HIV tat protein transduction domain are neither transduced between cells, nor exhibit enhanced immunogenicity. Gene Ther. 9:2002;1422-1428.
10. Richard J.P. Cell-penetrating peptides: a re-evaluation of the mechanism of cellular uptake. J. Biol. Chem. 278:2003;585-590.
11. Silhol M., et al. Different mechanisms for cellular internalization of the HIV-1 Tat-derived cell penetrating peptide and recombinant proteins fused to Tat. Eur. J. Biochem. 269:2002;494-501.
12. Kjellén L., Lindahl U. Proteoglycans: structures and interactions. Annu. Rev. Biochem. 60:1991;443-475.
13. Bernfield M., et al. Functions of cell surface heparan sulphate proteoglycans. Annu. Rev. Biochem. 68:1999;729-777.
14. Esko J.D., Selleck S.B. Order out of chaos: assembly of ligand binding sites in heparan sulfate. Annu. Rev. Biochem. 71:2002;435-471.
15. Faaber P., et al. Cross-reactivity of human and murine anti-DNA antibodies with heparan sulfate. The major glycosaminoglycan in glomerular basement membranes. J. Clin. Invest. 77:1986;1824-1830.
16. Cardin A.D., Weintraub H.J. Molecular modeling of protein-glycosaminoglycan interactions. Arteriosclerosis. 9:1989;21-32.
17. Park P.W., et al. Cell surface heparan sulfate proteoglycans: selective regulators of ligand-receptor encounters. J. Biol. Chem. 275:2000;29923-29926.
18. Mahley R.W., Ji Z.S. Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E. J. Lipid Res. 40:1997;1-16.
19. Fuki I.V., et al. The syndecan family of proteoglycans. Novel receptors mediating internalization of atherogenic lipoproteins in vitro. J. Clin. Invest. 100:1997;1611-1622.
20. Fuki I.V., et al. Perlecan heparan sulfate proteoglycan. A novel receptor that mediated a distinct pathway for ligand catabolism. J. Biol. Chem. 275:2000;25742-25750.
21. Colin S., et al. In vivo involvement of heparan sulfate proteoglycan in the bioavailability, internalization, and catabolism of exogenous basic fibroblast growth factor. Mol. Pharmacol. 1:1999;74-82.
22. Bai X., et al. Chinese hamster ovary cell mutants defective in glycosaminoglycan assembly and glucuronosyltransferase I. J. Biol. Chem. 274:1999;13017-13024.
23. Spillmann D. Heparan sulfate: anchor for viral intruders? Biochimie. 83:2001;811-817.
24. Shieh M.T., et al. Cell surface receptors for herpes simplex virus are heparan sulfate proteoglycans. J. Cell Biol. 116:1992;1273-1281.
25. Shukla D., et al. A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry. Cell. 99:1999;13-22.
26. Van Putten J.P.M., Paul S. Binding of syndecan-like cell surface proteoglycan receptors is required for Neisseria Gonorrhoeae entry into human mucosal cells. EMBO J. 14:1995;2144-2154.
27. Dehio C., et al. Ligation of cell surface heparan sulfate proteoglycans by antibody-coated beads stimulates phagocytic uptake into epithelial cells: a model for cellular invasion by Neisseria gonorrhoeae. Exp. Cell Res. 242:1998;528-539.
28. Mislick K.A., Baldeschwieler J.D. Evidence for the role of proteoglycans in cation-mediated gene transfer. Proc. Natl. Acad. Sci. U. S. A. 93:1996;12349-12354.
29. Sandgren S., et al. Nuclear targeting of macromolecular polyanions by an HIV-Tat derived peptide. Role for cell-surface proteoglycans. J. Biol. Chem. 277:2002;38877-38883.
30. Mounkes L.C., et al. Proteoglycans mediate cationic liposome-DNA complex-based gene delivery in vitro and vivo. J. Biol. Chem. 272:1998;26164-26170.
31. Belting M., et al. Proteoglycan involvement in polyamine uptake. Biochem. J. 338:1999;317-323.
32. Belting M., et al. Tumor attenuation by combined heparan sulfate and polyamine depletion. Proc. Natl. Acad. Sci. U. S. A. 99:2002;371-376.
33. Belting M., Petersson P. Protective role for proteoglycans against cationic lipid cytotoxicity allowing optimal transfection efficiency in vitro. Biochem. J. 342:1999;281-286.
34. Belting M., Petersson P. Intracellular accumulation of secreted proteoglycans inhibits cationic lipid-mediated gene transfer: co-transfer of glycosaminoglycans to the nucleus. J. Biol. Chem. 274:1999;19375-19382.
35. Wiethoff C.M., et al. The potential role of proteoglycans in cationic lipid-mediated gene delivery. Studies of the interaction of cationic lipid-DNA complexes with model glycosaminoglycans. J. Biol. Chem. 276:2001;32806-32813.
36. Green M., Loewen P.M. Autonomous functional domains of chemically synthesized human immunodeficiency virus Tat trans-activator protein. Cell. 55:1988;1179-1188.
37. Frankel A.D., Pabo C.O. Cellular uptake of the Tat protein from human immunodeficiency virus. Cell. 55:1988;1189-1193.
38. Schwarze S.R., et al. In vivo protein transduction: delivery of a biologically active protein into the mouse. Science. 285:1999;1569-1572.
39. Liu Y., et al. Uptake of HIV-Tat protein mediated by low-density lipoprotein receptor-related protein disrupts the neuronal metabolic balance of the receptor ligands. Nat. Med. 6:2000;1380-1387.
40. Tyagi M., et al. Internalization of HIV-1 Tat requires cell surface heparan sulfate proteoglycans. J. Biol. Chem. 276:2001;3254-3261.
41. Futaki S., et al. Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. J. Biol. Chem. 276:2001;5836-5840.
42. Suzuki T., et al. Possible existence of common internalization mechanisms among arginine-rich peptides. J. Biol. Chem. 277:2002;2437-2443.
43. Mai J., et al. Efficiency of protein transduction is cell-type-dependent and is enhanced by dextran sulfate. J. Biol. Chem. 277:2002;30208-30218.
44. Cheng F., et al. Nitric oxide-dependent processing of heparan sulfate in recycling S-nitrosylated glypican-1 takes place in caveolin-1-containing endosomes. J. Biol. Chem. 277:2002;44431-44439.
45. Nichols B.J., Lippincott-Schwartz J. Endocytosis without clathrin coats. Trends Cell Biol. 11:2001;406-412.
46. Liang Y., et al. Glypican and biglycan in the nuclei of neurons and glioma cells: presence of functional nuclear localization signals and dynamic changes in glypican during the cell cycle. J. Cell Biol. 139:1997;851-864.
47. Sciortino M.T., et al. Of the three tegument proteins that package mRNA in herpes simplex virions, one (VP22) transports the mRNA to uninfected cells for expression prior to viral infection. Proc. Natl. Acad. Sci. U. S. A. 99:2002;8318-8323.
48. Eguchi A., et al. Protein transduction domain of HIV-Tat protein promotes efficient delivery of DNA into mammalian cells. J. Biol. Chem. 276:2001;26204-26210.